Blue Chip Partners, Inc. Abbott Laboratories Transaction History

Blue Chip Partners, Inc.

$1.15 Billion
Q3 2024

A detailed history of Blue Chip Partners, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Blue Chip Partners, Inc. holds 178,074 shares of ABT stock, worth $20.6 Million. This represents 1.77% of its overall portfolio holdings.

Number of Shares

178,074

Previous 172,695 3.11%

Holding current value

$20.6 Million

Previous $17.9 Million 13.14%

% of portfolio

1.77%

Previous 1.66%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$100.07 - $118.13 $538,276 - $635,421	5,379 Added 3.11%	178,074 $20.3 Million
Q2 2024 Jul 29, 2024	BUY	$100.73 - $112.44 $1.09 Million - $1.22 Million	10,821 Added 6.68%	172,695 $17.9 Million
Q1 2024 Apr 25, 2024	BUY	$109.52 - $120.96 $1.8 Million - $1.99 Million	16,450 Added 11.31%	161,874 $18.4 Million
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $598,500 - $732,614	-6,636 Reduced 4.36%	145,424 $16 Million
Q3 2023 Oct 30, 2023	BUY	$95.53 - $114.62 $306,173 - $367,357	3,205 Added 2.15%	152,060 $14.7 Million
Q2 2023 Aug 02, 2023	BUY	$100.78 - $112.29 $496,946 - $553,701	4,931 Added 3.43%	148,855 $16.2 Million
Q1 2023 May 01, 2023	BUY	$96.86 - $114.01 $776,042 - $913,448	8,012 Added 5.89%	143,924 $14.6 Million
Q4 2022 Feb 01, 2023	BUY	$95.06 - $111.52 $2.6 Million - $3.05 Million	27,309 Added 25.15%	135,912 $14.9 Million
Q3 2022 Oct 27, 2022	BUY	$96.76 - $112.03 $40,348 - $46,716	417 Added 0.39%	108,603 $10.5 Million
Q2 2022 Aug 01, 2022	BUY	$102.07 - $123.37 $559,343 - $676,067	5,480 Added 5.34%	108,186 $11.8 Million
Q1 2022 May 04, 2022	BUY	$114.02 - $139.04 $1.2 Million - $1.46 Million	10,514 Added 11.4%	102,706 $12.2 Million
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $1.17 Million - $1.44 Million	10,165 Added 12.39%	92,192 $13 Million
Q3 2021 Nov 02, 2021	BUY	$116.66 - $129.06 $5.93 Million - $6.56 Million	50,822 Added 162.86%	82,027 $9.69 Million
Q2 2021 Aug 03, 2021	BUY	$105.79 - $124.53 $1,798 - $2,117	17 Added 0.05%	31,205 $3.62 Million
Q1 2021 May 04, 2021	SELL	$108.84 - $128.23 $66,065 - $77,835	-607 Reduced 1.91%	31,188 $3.74 Million
Q4 2020 Feb 05, 2021	BUY	$105.0 - $114.42 $32,550 - $35,470	310 Added 0.98%	31,795 $3.48 Million
Q3 2020 Oct 27, 2020	BUY	$91.64 - $111.29 $5,315 - $6,454	58 Added 0.18%	31,485 $3.43 Million
Q2 2020 Jul 30, 2020	SELL	$76.57 - $98.0 $918 - $1,176	-12 Reduced 0.04%	31,427 $2.87 Million
Q1 2020 May 08, 2020	SELL	$62.82 - $91.86 $301,096 - $440,284	-4,793 Reduced 13.23%	31,439 $2.48 Million
Q4 2019 Feb 11, 2020	SELL	$78.51 - $87.4 $10,363 - $11,536	-132 Reduced 0.36%	36,232 $3.15 Million
Q3 2019 Oct 29, 2019	SELL	$81.84 - $88.74 $10,066 - $10,915	-123 Reduced 0.34%	36,364 $3.04 Million
Q2 2019 Jul 31, 2019	SELL	$72.88 - $85.0 $4,518 - $5,270	-62 Reduced 0.17%	36,487 $3.07 Million
Q1 2019 Apr 23, 2019	SELL	$66.22 - $80.06 $46,155 - $55,801	-697 Reduced 1.87%	36,549 $2.92 Million
Q4 2018 Feb 05, 2019	SELL	$65.56 - $74.27 $100,044 - $113,336	-1,526 Reduced 3.94%	37,246 $2.69 Million
Q3 2018 Oct 26, 2018	SELL	$60.81 - $73.36 $433,636 - $523,130	-7,131 Reduced 15.53%	38,772 $2.84 Million
Q2 2018 Jul 25, 2018	SELL	$57.57 - $63.54 $454,975 - $502,156	-7,903 Reduced 14.69%	45,903 $2.8 Million
Q1 2018 Apr 25, 2018	BUY	$56.27 - $63.62 $205,948 - $232,849	3,660 Added 7.3%	53,806 $3.22 Million
Q4 2017 Jan 31, 2018	SELL	$53.68 - $57.47 $157,819 - $168,961	-2,940 Reduced 5.54%	50,146 $2.86 Million
Q3 2017 Nov 07, 2017	SELL	$48.06 - $53.64 $66,899 - $74,666	-1,392 Reduced 2.56%	53,086 $2.83 Million
Q2 2017 Aug 07, 2017	BUY	N/A	54,478	54,478 $2.65 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Chip Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blue Chip Partners, Inc. with notifications on news.

Account

Blue Chip Partners, Inc. Abbott Laboratories Transaction History